Eastern Asia: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in Eastern Asia

In 2021, the East Asian medicaments containing corticosteroid hormones market increased by 0.4% to $X, rising for the second year in a row after two years of decline. Overall, consumption saw a noticeable contraction. Over the period under review, the market reached the peak level at $X in 2012; however, from 2013 to 2021, consumption remained at a lower figure.

Production of Medicaments Containing Corticosteroid Hormones in Eastern Asia

In value terms, medicaments containing corticosteroid hormones production soared to $X in 2021 estimated in export price. Over the period under review, production saw a abrupt contraction. The pace of growth was the most pronounced in 2015 when the production volume increased by 46%. The level of production peaked at $X in 2012; however, from 2013 to 2021, production failed to regain momentum.

Exports of Medicaments Containing Corticosteroid Hormones

Exports in Eastern Asia

In 2021, approx. X tons of medicaments containing corticosteroid hormones were exported in Eastern Asia; growing by 23% on 2020 figures. Total exports indicated a buoyant expansion from 2012 to 2021: its volume increased at an average annual rate of +5.5% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +16.8% against 2018 indices. The pace of growth was the most pronounced in 2017 when exports increased by 32% against the previous year. The volume of export peaked in 2021 and is expected to retain growth in years to come.

In value terms, medicaments containing corticosteroid hormones exports surged to $X in 2021. The total export value increased at an average annual rate of +1.6% over the period from 2012 to 2021; however, the trend pattern remained relatively stable, with somewhat noticeable fluctuations throughout the analyzed period. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

China prevails in exports structure, recording X tons, which was near 82% of total exports in 2021. Japan (X tons) ranks second in terms of the total exports with a 7.2% share, followed by Hong Kong SAR (5.6%). South Korea (X tons) and Taiwan (Chinese) (X tons) followed a long way behind the leaders.

Exports from China increased at an average annual rate of +5.2% from 2012 to 2021. At the same time, Japan (+14.4%), Taiwan (Chinese) (+8.5%), Hong Kong SAR (+4.5%) and South Korea (+1.0%) displayed positive paces of growth. Moreover, Japan emerged as the fastest-growing exporter exported in Eastern Asia, with a CAGR of +14.4% from 2012-2021. From 2012 to 2021, the share of Japan increased by +3.7 percentage points. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Japan ($X) remains the largest medicaments containing corticosteroid hormones supplier in Eastern Asia, comprising 55% of total exports. The second position in the ranking was taken by China ($X), with a 23% share of total exports. It was followed by South Korea, with a 10% share.

From 2012 to 2021, the average annual growth rate of value in Japan was relatively modest. In the other countries, the average annual rates were as follows: China (+8.7% per year) and South Korea (+1.9% per year).

Export Prices by Country

In 2021, the export price in Eastern Asia amounted to $X per ton, declining by -2.7% against the previous year. In general, the export price showed a pronounced slump. The pace of growth appeared the most rapid in 2015 when the export price increased by 19% against the previous year. The level of export peaked at $X per ton in 2016; however, from 2017 to 2021, the export prices failed to regain momentum.

Prices varied noticeably country of origin: the country with the highest price was Japan ($X per ton), while China ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+3.3%), while the other leaders experienced more modest paces of growth.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in Eastern Asia

For the fourth year in a row, Eastern Asia recorded growth in overseas purchases of medicaments containing corticosteroid hormones, which increased by 1.6% to X tons in 2021. Total imports indicated prominent growth from 2012 to 2021: its volume increased at an average annual rate of +7.5% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +91.2% against 2012 indices. The most prominent rate of growth was recorded in 2016 with an increase of 22%. Over the period under review, imports hit record highs in 2021 and are expected to retain growth in the immediate term.

In value terms, medicaments containing corticosteroid hormones imports expanded modestly to $X in 2021. Total imports indicated a buoyant expansion from 2012 to 2021: its value increased at an average annual rate of +6.8% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +80.6% against 2012 indices. The pace of growth was the most pronounced in 2017 when imports increased by 13% against the previous year. The level of import peaked in 2021 and is expected to retain growth in the immediate term.

Imports by Country

In 2021, China (X tons) represented the major importer of medicaments containing corticosteroid hormones, constituting 57% of total imports. Japan (X tons) ranks second in terms of the total imports with a 32% share, followed by South Korea (6.1%). Taiwan (Chinese) (X tons) took a minor share of total imports.

From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Taiwan (Chinese) (with a CAGR of +10.9%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments containing corticosteroid hormones importing markets in Eastern Asia were China ($X), Japan ($X) and South Korea ($X), together comprising 96% of total imports. These countries were followed by Taiwan (Chinese), which accounted for a further 1.9%.

Taiwan (Chinese), with a CAGR of +10.8%, recorded the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Eastern Asia stood at $X per ton in 2021, almost unchanged from the previous year. Over the period under review, the import price, however, continues to indicate a relatively flat trend pattern. The pace of growth appeared the most rapid in 2017 an increase of 20%. The level of import peaked at $X per ton in 2014; however, from 2015 to 2021, import prices remained at a lower figure.

Prices varied noticeably country of destination: the country with the highest price was South Korea ($X per ton), while Taiwan (Chinese) ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by South Korea (+10.1%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :